Fed Rate Rise – The US Federal Reserve lifted rates a quarter of a percent on Thursday, beginning their move to keep inflation in check, and signalling another 6 rate rises this year alone. Forecasters are predicting US rates to rise to 1.9% by the end of 2022.
China Locked Down – A doubling in COVID cases in China, with more than 50 million people under lockdown has caused a sell-off in commodity and equity markets. Fears around supply chain disruptions have been raised at a time the global economy is already reeling from the Ukraine war.
Hydrogen Breakthrough – An Australian technology company, Hysata have had a major break through in development of an ultra-high efficient hydrolyser. It is understood that commercialisation of hydrogen energy will be possible once it can be produced at less than $2p/kg. Hysata believe they will achieve this comfortably by 2025.
ASX Recovers – The Australian share market has risen to its highest level since February 17 on Thursday. The 1.1% rise came off the back of a 25 basis point rate rise by the Fed, the first since 2018, and Australian unemployment hitting a 10 year low.
Dividend Payout – ASX listed companies are set to return over $36 billion to investors in the coming weeks as interim dividend payments. The large haul is helped by 88% of companies listed on the ASX 200 reporting a first-half profit.
Click here to open a POEMS trading account
Disclaimer
This publication has been prepared solely for the information of the particular person to whom it was supplied by Phillip Capital Limited (“PhillipCapital”) AFSL 246827. This publication contains general securities advice. In preparing the advice, PhillipCapital has not taken into account the investment objectives, financial situation and particular needs of any particular person. Before making an investment decision on the basis of this advice, you need to consider, with or without the assistance of a securities adviser, whether the advice in this publication is appropriate in light of your particular investment needs, objectives and financial situation. PhillipCapital and its associates within the meaning of the Corporations Act may hold securities in the companies referred to in this publication. PhillipCapital believes that the advice and information herein is accurate and reliable, but no warranties of accuracy, reliability or completeness are given (except insofar as liability under any structure cannot be excluded). No responsibility for any errors or omissions or any negligence is accepted by PhillipCapital or any of its directors, employees or agents. This publication must not be distributed to retail investors outside of Australia.